Manage Your Liver
Q:

Warning! Think twice before you use DAA treatment.

Warning! Think twice before you use DAA treatment.
A:

In our last post, we brought up the recent findings on extreme liver cancer growth after successful DAA treatment. We are talking about liver cancer of a few centimetres developed within weeks of successful Hep C treatment. These findings are also observed in patients of Gastroenterology. Dr. Roushdi Khalf allah said, “That is a real observation I also faced with my patients in Egypt.” [1]

 

We have also received a number of comments and enquiries from readers who have experienced the same problem mentioned. Many people found this result shocking. This indicates the extreme growth of liver cancer does exist in patients and more importantly, not enough patients are realizing the post treatment risks.

 

The cause of extreme liver cancer growth

The cause of this extreme liver cancer growth is still unclear at this moment, doctors and researchers can only confirm that this type of cancer growth in patients with hepatitis C and cirrhosis is abnormal by saying “A 30% rate over 3 years from initial surgery or ablation is normal. What was surprising to us was that we were observing 4 cm lesions after 12 weeks.” [1]

 

Lead investigator Stefano Brillanti, MD, from the University of Bologna, Italy said that "The hypothesis is that immune surveillance may be reduced too rapidly”. This means that the sudden reduction in virus count and immune surveillance might be the reason behind the growth of abnormal liver cells into large cancers. In another words, he is suggesting that while DAAs can eliminate the viruses, they might have negative impact on your immune system, allowing cancer cells to grow freely.

 

No warnings from doctors, yet.

AASLD (American Association for the Study of Liver Diseases) has already begun asking patients to have regular check-ups to closely monitor liver status even after successful treatment.[2] Most doctors also recommend patients to go back for regular monitoring. But at this stage, it seems that not many doctors realize the potential risks and undoubtedly they are not giving enough warning or information to potential DAA clients.

 

Will everyone get it?

Although an increasing number of  cases are being reported as more patients have received treatment in recent years, it seems that the percentage of patients that will go on to develop extreme cancer still remains relatively low. More concrete figures should be available as more research work is carried out.

 

Would you take the risk?

The big question here is that if you are currently considering treatment, should you go for it? Considering the drawbacks such as the high cost of treatment and uncertain potential risks, the wise move for now might be to allow more time for research and studies and wait for clearer information to become available.

During the wait, it is important to control liver health and liver function. By preventing inflammation and damage caused by hep C virus, liver injury can be prevented and hep C patients can live a healthy life without undergoing anti viral treatment.

 

If you worry about anti-viral treatment or would like to know more about how to maintain healthy liver function and living in harmony with hep C, please send your questions to our support team.

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
DAA treatment YHK therapy cirrhosis treatment hepatitis C treatment hep C cirrhosis
Related Questions
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us